What Does Ardelyx, Inc. Do?

Total employees425
HeadquartersFremont
Founded2007

Ardelyx, Inc. is a specialized biopharmaceutical company dedicated to the discovery, development, and commercialization of novel, first-in-class, oral, small molecule therapeutics that target new pathways to treat patients with cardiorenal and gastrointestinal (GI) diseases with significant unmet medical needs. Their flagship products include IBSRELA® (tenapanor) for Irritable Bowel Syndrome with Constipation (IBS-C) in adults, and XPHOZAH® (tenapanor), for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Ardelyx is committed to advancing patient care through innovative science and targeted therapies.

Where Is Ardelyx, Inc.'s Headquarters?

Ardelyx, Inc. officeArdelyx, Inc. officeArdelyx, Inc. officeArdelyx, Inc. office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters serves as the central hub for Ardelyx's corporate leadership, research and development (R&D) activities, clinical operations, commercial strategy, and administrative support functions.

Notable Features:

Modern office and laboratory facilities, including state-of-the-art R&D labs and collaborative workspaces designed to foster innovation and support biopharmaceutical development.

Work Culture:

A dynamic and patient-centric work culture that encourages innovation, collaboration, and scientific excellence. Employees often experience a fast-paced environment typical of growth-stage biopharmaceutical companies, focused on achieving breakthroughs for patients.

HQ Significance:

The Fremont headquarters is critical for Ardelyx as it centralizes all strategic decision-making, core research, product development, and operational management, enabling the company to advance its pipeline and commercial products.

Values Reflected in HQ: The headquarters likely reflects Ardelyx's commitment to scientific discovery, patient well-being, and collaborative teamwork through its functional design, investment in R&D infrastructure, and an environment conducive to innovation.

Location:

Ardelyx is primarily focused on the development and commercialization of its treatments within the United States. For regions outside the U.S., Ardelyx selectively enters into strategic partnerships to support the development and commercialization of its product candidates. They have existing collaborations for tenapanor in markets such as Japan, China, and Canada, extending the reach of their innovative therapies globally through these partners.

Street Address:

34175 Ardenwood Blvd

City:

Fremont

State/Province:

CA

Country:

USA

Where Else Does Ardelyx, Inc. Operate Around the World?

No additional office locations available.

Buying Intent Signals for Ardelyx, Inc.

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ardelyx, Inc.? Meet the Executive Team

As of April 2025, Ardelyx, Inc.' leadership includes:

Mike Raab - President and Chief Executive Officer
Justin Renz - Chief Financial Officer and Chief Operating Officer
Susan Rodriguez - Chief Commercial Officer
Laura Williams, M.D., MPH - Chief Medical Officer
Robert Blanks, R.Ph. - Chief Regulatory Affairs and Quality Assurance Officer
Elizabeth S. Posillico, Ph.D. - Chief Scientific Officer
Janice M. McCourt - Chief People and Culture Officer

Who's Investing in Ardelyx, Inc.?

Ardelyx, Inc. has been backed by several prominent investors over the years, including:

NEA Management Company, LLC
BlackRock Inc.
The Vanguard Group, Inc.
Deerfield Management Company, L.P.
State Street Corporation

What Leadership Changes Has Ardelyx, Inc. Seen Recently?

Hire1
Exits0

In the last 12 months, Ardelyx has strengthened its leadership team with a key new hire in People and Culture and a significant internal promotion within its regulatory affairs division. No high-profile executive departures were publicly announced during this period.

New Appointments:

Janice M. McCourt, Janice M. McCourt appointed as new Chief People and Culture Officer.
Robert N. Blanks, R.Ph., Robert N. Blanks promoted to Chief Regulatory Affairs and Quality Assurance Officer.

What Technology (Tech Stack) Is Used byArdelyx, Inc.?

Discover the tools Ardelyx, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ardelyx, Inc. Email Formats and Examples

Ardelyx, Inc. commonly uses the 'first initial followed by last name' email format. Understanding this pattern can be useful for professional communication.

flast@ardelyx.com

Format

mraab@ardelyx.com

Example

85%

Success rate

What's the Latest News About Ardelyx, Inc.?

GlobeNewswire via Yahoo FinanceMay 9, 2024

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

Ardelyx reported total revenue of $56.6 million for Q1 2024, primarily driven by IBSRELA sales. The company provided updates on its commercial products and pipeline development, highlighting strong U.S. launch of IBSRELA and ongoing efforts for XPHOZAH....more

GlobeNewswireApril 2, 2024

Ardelyx Announces Publication of Data from Two Phase 3 Trials of XPHOZAH® (tenapanor) in the Journal of the American Society of Nephrology

Data from two pivotal Phase 3 trials for XPHOZAH (tenapanor) in adult patients with chronic kidney disease (CKD) on dialysis were published in the Journal of the American Society of Nephrology (JASN), supporting its efficacy in reducing serum phosphorus....more

GlobeNewswireFebruary 29, 2024

Ardelyx Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Ardelyx announced its financial results for the fourth quarter and full year ended December 31, 2023, highlighting significant revenue growth from IBSRELA sales and progress across its portfolio....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ardelyx, Inc., are just a search away.